Low-density lipoprotein cholesterol lowering treatment: the current approach
Abstract In the last 50 years, several clinical and epidemiological studies during have shown that increased levels of low-density lipoprotein cholesterol (LDLc) are associated with the development and progression of atherosclerotic lesions. The discovery of β-Hydroxy β-methylglutaryl-CoA reductase...
Main Authors: | Irina Crismaru, Anca Pantea Stoian, Ovidiu Gabriel Bratu, Mihnea-Alexandru Gaman, Ana Maria Alexandra Stanescu, Nicolae Bacalbasa, Camelia Cristina Diaconu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-05-01
|
Series: | Lipids in Health and Disease |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12944-020-01275-x |
Similar Items
-
What is new regarding the treatment of dyslipidemia in the 2019 European Society of Cardiology Guidelines?
by: Madalina A. MUNTEANU, et al.
Published: (2019-12-01) -
Asociation of PCSK9 with Low Density Lipoproteins (LDL) in the Regulation of LDL-Cholesterol Levels
by: Sarkar, Samantha Khadija
Published: (2015) -
Editorial: Genetics of Familial Hypercholesterolemia: New Insight
by: Alpo Vuorio, et al.
Published: (2021-05-01) -
Correlation of PCSK9 and Serum sdLDL Levels and Other Demographic and Laboratory Indicators in Healthy Individuals
by: Reza Hosseini-Fard, et al.
Published: (2018-05-01) -
<i>Acanthaster planci</i> Inhibits PCSK9 and Lowers Cholesterol Levels in Rats
by: Nurjannatul Naim Kamaruddin, et al.
Published: (2021-08-01)